Q1 2025 CVRx Inc Earnings Call Transcript

May 8, 2025 / 08:30 PM GMT

Release Date Price: $7.78 (+4.01%)

Transcript 10-Q8-K

Key Points

Positve

CVRx Inc (CVRX) reported a 15% revenue growth in Q1 2025 compared to the prior year, reaching $12.3 million.
The company has successfully attracted high-quality sales talent, which is expected to improve productivity and account stabilization throughout the year.
CVRx Inc (CVRX) is focusing on building a world-class sales organization with a new compensation plan that aligns with their program-focused selling approach.
The company is targeting centers with high potential for sustainable Barostem programs, showing an increase in qualifying centers in Q1.
Recent clinical evidence shows significant reductions in hospital visits post-Barostem implantation, which has been well-received by physicians and payers.

Negative

Revenue performance fell short of expectations due to Salesforce realignment and seasonality factors.
The realignment of the sales force caused short-term disruptions, impacting account-level performance.
25% of territory managers were newly hired between December and March, leading to varied productivity levels.
The company experienced a decrease in sales territories in the US, from 48 to 45 during Q1 2025.
Net loss for Q1 2025 was $13.8 million, although it was an improvement from the $22.2 million loss in Q1 2024.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

CVRX.OQ - CVRx Inc
Q1 2025 CVRx Inc Earnings Call
May 08, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day everyone, and welcome to today's CVRX Q1 2025 earnings call.

At this time, all participants are in a listen-only mode.

Later, you will have the opportunity to ask questions during the question and answer session.

You may register to ask a question at any time by pressing one on your telephone keypad.

Please note this call is being recorded.

I will be standing by if you should need any assistance.

It is now my pleasure to turn the conference over to Mike Valley from ICR Healthcare. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.